About Rea Diagnostics
Rea Diagnostics is a company based in Lausanne (Switzerland) founded in 2020 by Loulia Kassem and Erick Antonio Garcia Cordero. Rea Diagnostics offers products and services including Smart Sanitary Pad. Rea Diagnostics operates in a competitive market with competitors including Ava and Pregnolia, among others.
- Headquarter Lausanne, Switzerland
- Founders Loulia Kassem, Erick Antonio Garcia Cordero
-
Sectors
ConsumerHealthcare Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$115.16 K (USD), Debt – Conventional
Jan 22, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rea Diagnostics
Rea Diagnostics offers a comprehensive portfolio of products and services, including Smart Sanitary Pad.
Detects biomarkers to predict preterm birth risks for early medical alerts.
Funding Insights of Rea Diagnostics
Investors in Rea Diagnostics
Rea Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FIT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Grants and loans are provided by FIT for innovative startups.
|
Locked | Locked | Locked |
Investor details for Rea Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rea Diagnostics
Investment portfolio details for Rea Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rea Diagnostics
Detailed financials for Rea Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rea Diagnostics Comparisons
Peer comparison for Rea Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rea Diagnostics
Rea Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ava and Pregnolia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based transcription and captioning services are provided for multiple applications.
|
|
| Locked | Locked | Locked |
Preterm birth risks are predicted using cervical stiffness measurement devices.
|
Detailed competitors of Rea Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rea Diagnostics
Complete news archive for Rea Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rea Diagnostics
Rea Diagnostics was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Rea Diagnostics is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Loulia Kassem is the current CEO of Rea Diagnostics. They have also founded this company.
Rea Diagnostics was founded in 2020 in Lausanne, Switzerland, and operates in the medical diagnostics sector. An at-home smart sanitary pad is developed by the company to track biochemical markers associated with preterm birth. This device enables early intervention by doctors, aiming to reduce neonatal mortalities. The focus is placed on wearable technology for remote monitoring in womens health.
Rea Diagnostics offers Smart Sanitary Pad.
Rea Diagnostics has 1 investor. Key investors include FIT.